ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2026
Evaluation of a sequestrant used to reduce aflatoxin M
Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fungal grains contamination must be avoided, since the quality and safety of feed conditions are determinants for animal health. The objective of this study was to evaluate the ability of a sequestrant agent to reduce the bioavailability of aflatoxins in the animal organism. A diet contaminated with a total daily dose of 1140 µg of Aflatoxin B1 (AFB1), and another diet with the same concentration of AFB1 and 50 g of sequestrant MYCO-AD (Special Nutrients, EEUU), were administered to dairy cows in production. The concentrations of Aflatoxin M1 (AFM1) (µg/L) in milk were quantified by HPLC-fluorescence detection; in urine, AFM1 was quantified by ELISA. Blood samples were collected from the coccyx of all cows to determine their metabolic profiles, including energy levels, liver function indicators, protein levels and ionic balance biomarkers, using colorimetric assay. Milk production and concentrations of AFM1was recorded throughout the experiment. During the feeding period, milk production of the group fed a diet artificially contaminated with AFB1 was compared to the group treated with feed artificially contaminated with AFB1 and the sequestrant. Quantification of AFM1 in urine can be used to determine exposure to these mycotoxins in non-lactating animals. The results showed that the global transfer rate of AFB1 to AFM1 in milk was more than halved form 1.04% in the control group to 0.48% in the MYCO-AD group. The milk production was not affected by the inclusion of the sequestrant. The sequestrant reduces the bioavailability of AFB1 without affecting the production and health of the cows.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.